CurrentBlue Cross Blue Shield - MassachusettsPolicy 792

Dry Needling of Myofascial Trigger Points

This policy governs coverage of dry needling of myofascial trigger points for Commercial Blue Cross Blue Shield - Massachusetts members (Managed Care HMO/POS, PPO, Indemnity) and specifies prior authorization and inpatient precertification requirements.

Policy Summary

PayerBlue Cross Blue Shield - Massachusetts

PolicyDry Needling of Myofascial Trigger Points

Policy CodePolicy 792

Change TypeNo material change

Effective Date

Next Review Date

Key ActionObtain inpatient precertification/preauthorization when performing services described in this policy in an inpatient setting.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

InvestigationalPolicy stance (commercial)

Not coveredOutpatient coverage

20560–20561Investigational CPTs

Inpatient requiredPreauth

Systematic reviewsEvidence

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Determinations

Coverage stance

Policy determination:

Investigational determination: Dry needling of trigger points for the treatment of myofascial pain is considered investigational for Commercial Members (Managed Care HMO/POS, PPO, and Indemnity).

Policy statement

For Commercial Members (Managed Care HMO/POS, PPO, and Indemnity), outpatient dry needling of trigger points is not a covered service. Claims for outpatient dry needling for these commercial products may be denied based on noncoverage.

The available evidence from randomized controlled trials and systematic reviews is limited and methodologically heterogeneous. For neck/shoulder and plantar heel myofascial pain, systematic reviews found no consistent, clinically important benefit of dry needling compared with placebo or other physical therapy modalities; trials were limited by small sample sizes, risk of bias, and inconsistent blinding. For temporomandibular myofascial pain, two RCTs (including one double‑blind, sham‑controlled trial) showed no consistent differences in pain or function versus control. Overall, the evidence is insufficient to determine that dry needling of trigger points improves net health outcomes.

Procedure and Billing Codes

Investigational CPT CodesCPTNot Covered

20560	Needle insertion(s) without injection(s); 1 or 2 muscle(s).
20561	Needle insertion(s) without injection(s); 3 or more muscles.

Provider Requirements and Billing Guidance

Prior Authorization

Inpatient precertification required

For services described in this policy, precertification/preauthorization is required when the procedure is performed inpatient.

Applies to all products when performed inpatient

Note

Provider responsibilities

(Placeholder) Provider should follow applicable precertification and billing processes and check member contract benefits. Document medical necessity in the medical record.

Documentation Required

Coding and documentation guidance

Clinical Background

Myofascial trigger points are discrete, focal, hyperirritable spots within a taut band of skeletal muscle fibers that can produce local and/or referred pain when stimulated. Dry needling is a procedure in which a fine needle is inserted into the skin and muscle at a trigger point, often with the goal of eliciting a local twitch response to reduce pain. Techniques vary (for example, deep approaches aiming for a twitch response versus more superficial approaches), and proposed physiologic mechanisms differ across studies. Clinical trials and reviews have evaluated dry needling for pain, function, quality of life, and treatment‑related morbidity, but methodological limitations in the literature limit definitive conclusions about efficacy.

Key Definitions

Myofascial trigger points — definition

TermMyofascial trigger points

DefinitionDiscrete, focal, hyperirritable spots within a taut band of skeletal muscle fibers that produce local and/or referred pain when stimulated.

PathophysiologyLikely result from injury to muscle fibers; exact mechanisms not fully defined.

Clinical relevanceAssociated with myofascial pain; may be visualized by MRI and elastography; manual identification reliability not established.

Dry needling — definition

TermDry needling

Definition

Policy Summary

PayerBlue Cross Blue Shield - Massachusetts

PolicyDry Needling of Myofascial Trigger Points

Policy CodePolicy 792

Change TypeNo material change

Effective Date

Next Review Date

Key ActionObtain inpatient precertification/preauthorization when performing services described in this policy in an inpatient setting.

SourceLink

On This Page

Report services with current, industry-standard procedure, revenue, and diagnosis codes, including modifiers where applicable.

Providers should use most up-to-date CPT/HCPCS/ICD-10 and modifier codes
Inclusion or exclusion of a code in the policy does not guarantee coverage — check member contract benefits

Denial Risk

Outpatient noncoverage notice

Dry needling of trigger points is not a covered outpatient service for Commercial Managed Care (HMO and POS), Commercial PPO, and Indemnity; outpatient claims may be denied as not covered.

Commercial Managed Care (HMO and POS), Outpatient = Not a covered service
Commercial PPO and Indemnity, Outpatient = Not a covered service

Denial Risk

Investigational service — potential denial

Dry needling of trigger points is considered investigational for Commercial Members (Managed Care HMO and POS, PPO, and Indemnity); services may be denied as investigational.

Investigational for Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity

A procedure in which a fine needle is inserted into the skin and muscle at a site of myofascial pain without injection of medications.

TechniquesMay include deep dry needling (aiming for a local twitch response) and superficial dry needling; needle may be moved, rotated, or left in place up to 30 minutes.

PurposeIntended to stimulate underlying trigger points, muscles, and connective tissues to manage myofascial pain and reduce pain or impairments.

Needle typesPerformed with acupuncture needles or standard hypodermic needles but without injecting medications.